By vgreene, 8 April, 2020 Make in-pt vs out-pt decision on case-by-case basis; will depend on clinical presentation, requirement for supportive care, risk factors for severe dz,1 ability to self-isolate at home
By vgreene, 8 April, 2020 Pts w/ mild presentation (no pneumonia or hypoxia) may not initially require hospitalization
By vgreene, 8 April, 2020 FDA has issued guidance on administering or studying use of convalescent plasma for tx
By vgreene, 8 April, 2020 FDA issued an emergency use authorization to authorize use of the drugs from the national stockpile to treat hospitalized adults and adolescents (wt ≥50 kg) for whom a clinical trial isn’t available or participation not feasible
By vgreene, 8 April, 2020 Under investigation in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infxn, and tx of mild, moderate, and severe COVID-19